In this randomized-controlled, cross-over trial the investigators test the effect of long-term oxygen therapy (\> 16h/day) given for 5 weeks with a wash-out period between phases of 2 weeks on exercise performance and quality of life and many physiological parameters in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
30
University Hospital Zurich, Division of Pneumology
Zurich, Canton of Zurich, Switzerland
6 minute walk test
6 minute walk distance according to american thoracic society (ATS) guidelines
Time frame: 5 weeks
Quality of life
QoL assessed by the short form of the medical outcome questionnaire (SF-36) physical functioning scale
Time frame: 5 weeks
Daily activity
measured by actigraphy
Time frame: 5 week
hemodynamics by echocardiography
Full echocardiographic assessment
Time frame: 5 weeks
quality of life
SF-36
Time frame: 5 weeks
arterial blood gas
partial pressure of oxygen (PaO2)
Time frame: 5 weeks
operating hours of oxygen concentrator
efficacy of oxygen treatment
Time frame: 5 weeks
mean nocturnal oxygen saturation
Ambulatory Sleep Study
Time frame: 5 weeks
tests of cognitive performance
STROOP-Test
Time frame: 5 weeks
Quality of life
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Minnesota living with heart failure questionnaire
Time frame: 5 weeks
Venous blood
N-terminal brain natriuretic peptide (NT-proBNP)
Time frame: 5 weeks